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In this perspective, we propose the absence of detailed information regarding spinal cord
circuits that process sensory information remains a major barrier to advancing analgesia.
We highlight recent advances showing that functionally discrete populations of neurons
in the spinal cord dorsal horn (DH) play distinct roles in processing sensory information.
We then discuss new molecular, electrophysiological, and optogenetic techniques that can
be employed to understand how DH circuits process tactile and nociceptive information.
We believe this information can drive the development of entirely new classes of
pharmacotherapies that target key elements in spinal circuits to selectively modify sensory
function and blunt pain.
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INTRODUCTION
Pain is an important percept within our somatosensory system. It
provides an alert to actual or potential tissue damage and ensures
injured tissue is protected during healing (Basbaum et al., 2009).
Despite its important biological function, the unpleasant nature
of pain and its tendency to often outlast the initial stimulus has
driven a search for strategies to relieve it for many millennia. For
example, Sumerian clay tablets (∼3400 BC) refer to opium culti-
vation for pain relief, and to this day opium derivatives remain the
gold standard for treating moderate and severe pain (Rosenblum
et al., 2008). The fact that an age-old analgesic remains at the front-
line of pain treatment emphasizes the slow progress in analgesic
research. Together with the problematic side effects of opiates,
their addiction and abuse potential, and the “opiate resistance”
of many chronic pain conditions (including neuropathic pain)
these factors reinforce the urgent need to identify and develop
new analgesics (de Leon-Casasola, 2013).
The neuronal pathways that transmit nociceptive signals to the
brain contain multiple sites that present opportunities to phar-
macologically alter signaling and ultimately inﬂuence or block
the pain experience. This complex task of sensing, encoding and
perceiving stimuli that could generate pain begins with the col-
lection of information in peripheral sensory receptors, termed
nociceptors. Nociceptors are located throughout our body in
skin, muscle, joints and viscera, forming diverse populations
that can encode either exclusively or combinations of high inten-
sity thermal, mechanical and chemical stimuli. The mechanisms
that lead to nociceptor activation and sensitisation obviously pro-
vide potential analgesic targets [for review see (Stein et al., 2009;
Richards and McMahon, 2013)]. However, targeting peripheral
components of the nociceptive system has little value in pain
conditions where aberrant signaling, in the form of hyperactive
neuron populations and circuits, is ﬁrmly established in the central
nervous system (CNS).
Here we focus on the spinal cord dorsal horn (DH), the ﬁrst
site where nociceptive information enters the CNS, is processed,
and subsequently relayed through successively higher levels of the
neuroaxis to form a sensory percept. The necessity for nociceptive
information to pass through the DH and ascend to higher brain
structures before pain is experienced makes it an attractive site
for pharmacological targeting. Indeed, this has been well accepted
since publication of the gate control theory of pain by Melzack
and Wall (1965). Furthermore, we now know that both peripheral
and central insults can disrupt normal information ﬂow through
the neuroaxis by initiating reorganization of circuits in the spinal
cord DH, brainstem, thalamus, limbic, or cortical regions and
produce altered sensory perception in conditions such as neu-
ropathic pain or itch (Graham and Callister, 2012). Given this
longstanding focus it is not unreasonable to ask,“Whyhas progress
in spinal-based analgesics been so slow”?
We believe an answer to this question may lie in our overly
simpliﬁed view of the DH. The general view is that this spinal
region acts as a single processing unit, even though we know it
receives diverse signals from thermal, nociceptive, pruritic (itch),
and tactile peripheral receptors. Thus, neurons in the DH must
simultaneously fulﬁl several roles, which are critical for normal
sensory experience: i.e., the integration of different types of sig-
nals and segregation of others into speciﬁc ascending pathways
(Todd, 2010). A classic example is the segregation of nociceptive
and tactile information in the DH. This ensures peripheral stimuli
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such a sharp pin-prick or light touch result in very different and
contextually relevant sensory experiences. One of the critical sub-
strates for these processing tasks is the diversity of neuron types,
which form DH circuits and have very speciﬁc properties. Sur-
prisingly, our knowledge of the discrete neuronal types within DH
circuits and their precise role in sensory processing is limited.
These gaps in our knowledge exist because of historical lim-
itations in experimental approaches. Until recently spinal cord
researchers have generally been forced to collect data from multi-
ple (unidentiﬁed) neuronal classes and then“pool” these results to
provide an“averaged view”of sensory processing and function (or
dysfunction). This approach clearly overlooks cell-type diversity in
the DH as originally observed by Ramon y Cajal (1899) more than
a century ago. Since Cajal’s work there has been general agree-
ment that if we are to understand nervous system function, we
must ﬁrst understand how neuron types are assembled into pro-
cessing circuits. Armed with this mechanistic understanding, we
may then identify putative drug targets on speciﬁc neuron types.
We believe this approach offers the promise of targeted analgesics
that selectively act on nociceptive circuits.
At the same time, it is important to acknowledge that the
difﬁculty in deﬁning functionally discrete neuron populations
within the DH is not due to a lack of effort. In fact, an exten-
sive literature shows that multiple neuron classes do exist as
based on any single parameter (e.g., electrophysiology, neuro-
chemistry, morphology). For example, inhibitory interneurons
in the superﬁcial DH can be differentiated into four popula-
tions based on the non-overlapping expression of neurochemical
markers (neuropeptide Y, galanin, parvalbumin, and nitric oxide
synthase; Polgár et al., 2013). The same approach reveals up
to six populations of excitatory interneurons (calretinin, cal-
bindin, neurotensin, somatostatin, substance P, and neurokinin
B; Todd, 2010), though some overlap exists within expression
patterns. In contrast, electrophysiological classiﬁcation distin-
guishes four to seven types of neurons based on action potential
discharge patterns during depolarizing current injection (Grudt
and Perl, 2002; Ruscheweyh and Sandkuhler, 2002; Graham,
2004). Finally, using anatomical criteria, four distinct morpholo-
gies are commonly differentiated (Grudt and Perl, 2002; Yasaka
et al., 2010). The challenge has been to merge this information
into a model that deﬁnes neuron populations with homogenous
properties based on multiple criteria. Only with this infor-
mation can we begin to understand how DH circuits process
both nociceptive and non-nociceptive information and develop
tools that allow us to manipulate this region and provide pain
relief.
SPINAL SUBPOPULATIONS MATTER FOR PAIN PROCESSING
IN THE DH
Some evidence is now accumulating to support a key role for
functionally andneurochemically distinct neuronal populations in
spinal sensory processing. For example, recent work has examined
the role of excitatory DH interneurons in pain and itch. In these
experiments knockout of the testicular orphan nuclear receptor 4
(TR4) in the CNS resulted in a substantial loss (∼70%) of exci-
tatory interneurons (Wang et al., 2013). Behavioral analyses then
identiﬁed an almost complete loss of supraspinally mediated pain
and itch responses, elevated mechanical withdrawal thresholds,
andnerve injury-inducedmechanical hypersensitivity. In contrast,
noxious heat evoked reﬂexes that originate in the spinal cord, nerve
injury-induced heat hypersensitivity, and tissue injury-induced
heat and mechanical hypersensitivity were unaltered. The authors
concluded,“that different subsets of dorsal excitatory interneurons
contribute to tissue and nerve injury-induced heat and mechan-
ical pain” (Wang et al., 2013). This study complements a larger
body of work, which began with the gate control theory of pain,
implicating populations of inhibitory (GABA and glycine contain-
ing) DH interneurons in nociceptive processing (Zeilhofer et al.,
2011). This work has ﬁrmly established that inhibitory dysfunc-
tion allows “linking” of tactile and nociceptive circuits to produce
allodynia and hyperalgesia. The search for speciﬁc neuronal sub-
populations directly involved in this process has unfortunately
progressed slowly.
Despite the above challenges, work on inhibitory interneurons
has succeeded in identifying a functionally distinct neuronal sub-
population in the DH (Ross et al., 2010). This work, which is
relevant to itch rather than nociception, assessed the role of a
particular transcription factor – Bhlhb5. Mice lacking Bhlhb5
exhibited an itch phenotype and lacked a subset of inhibitory
interneurons in the DH. Importantly, the remaining neuronal
populations, afferent input, and responses to other sensorymodal-
ities were not altered. This conﬁrmed a speciﬁc role for the
lost inhibitory population in the processing of itch-related stim-
uli. Together with the data on excitatory populations, this work
provides support for the hypothesis that additional unidentiﬁed
interneuron subpopulations exist in the DH.
TARGETING SPINAL SUBPOPULATIONS
Over the last decade, transgenic techniques have been developed
which allow marker proteins such as green ﬂuorescent protein
(GFP) to be expressed in speciﬁc neurons, thereby enabling us
to visualize and target speciﬁc neuronal subtypes in the CNS. In
simple terms, this is achieved by genetic techniques that couple
GFP expression to a promoter protein that only exists in neu-
rons of interest. As long as we have a “genetic signature” for
a given neuron type, this approach allows us to address DH
interneuron diversity. To date, such studies have been restricted to
inhibitory interneurons whereby GFP expression has been linked
to proteins involved in neurotransmitter synthesis and membrane
transport (Heinke, 2004; Zeilhofer et al., 2004). This work has,
however, still reported signiﬁcant variability in the properties
of targeted populations in GFP-positive neurons. Nevertheless,
speciﬁcally studying GABAergic interneurons labeled by GFP has
produced important ﬁndings. For example, a small subpopu-
lation of GFP-positive neurons has been identiﬁed that receive
low-threshold (tactile) input from primary afferents (Daniele and
MacDermott, 2009). The ability of these tactile inputs to acti-
vate GABAergic interneurons has long been acknowledged as a
basic requirement for inhibitory circuits to “segregate” nocicep-
tive and tactile information. While such transgenic approaches
provide a powerful tool to study subpopulations of neurons, it
seems identifying speciﬁc target proteins to drive GFP expres-
sion in these populations (i.e., the neuron’s genetic “signature”)
is challenging (Graham et al., 2007). For example if the aim is to
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identify discrete classes of neurons with uniform properties and
clear roles in sensory processing, labeling neurons based upon
the primary neurotransmitter they employ appears too crude an
approach.
With these challenges in mind, we have recently characterized
a small but signiﬁcant subpopulation of inhibitory interneu-
rons that express the calcium-binding protein parvalbumin (PV;
Hughes et al., 2012). This work places PV-positive interneurons
in a putative circuit for mediating feed-forward inhibition in
the DH (Figure 1). Using GFP to target PV-expressing neu-
rons we showed that the functional and morphological proper-
ties of PV-positive interneurons were remarkably homogeneous.
PV-positive interneurons exhibited excitable, high frequency AP
discharge responses and typically had islet like morphologies. Fur-
thermore, a signiﬁcant proportion (∼80%) of axons arising from
PV-positive DH neurons made selective axoaxonic-synapses onto
the central terminals of myelinated afferents. We also showed that
PV-positive interneurons received input from the samemyelinated
afferent population. This connectivity is ideally suited to main-
tain functional segregation of sensory modalities. Thus, under
normal conditions when tactile related information arrives in
the DH, PV-neurons are excited and subsequently inhibit tac-
tile inputs. This action prevents further excitation that would
otherwise recruit nociceptive circuits (Figure 1). By extension,
decreased PV-neuron excitability would remove this gating of
tactile information, link tactile and nociceptive signaling and
produce tactile allodynia. An important caveat to this work is
that despite the success of our PV targeting approach, some
heterogeneity remained in our sample. Speciﬁcally, 20% of the
axons arising from PV-positive neurons targeted unidentiﬁed
structures and some variability remained in our electrophysio-
logical and morphological data. In summary, our ﬁndings in the
PV-GFP mouse, along with earlier GFP studies, suggest additional
analyses are required to uncover more discrete neuronal subpop-
ulations and determine their functional role in spinal sensory
processing.
NEW TOOLS TO DEFINE FUNCTIONALLY DISCRETE
SUBPOPULATIONS
Fortunately, a number of techniques are becoming available which
could expand our analysis of DH neuron subpopulations. For
example, several groups have used molecular screening techniques
to dissect neuronal heterogeneity. This has only recently been
applied to the DH (Wildner et al., 2013). Here two transgenic
mice, which lacked key transcriptional regulators that normally
deﬁne inhibitory DH interneuron lineages, were subjected to
molecular screening. Genome-wide expression comparisons iden-
tiﬁed four genes (pDyn, Kcnip2, Rorb, and Tfap2b) with largely
non-overlapping expression patterns that were signiﬁcantly down
regulated in the DH of animals lacking inhibitory interneuron
populations (Wildner et al., 2013). The group is now testing how
subpopulations that selectively express these four genes contribute
to sensory and nociceptive processing in the DH. A variation of
this strategy has also been applied to a number of CNS regions
whereby gene expression proﬁling is undertaken in individual, or
small numbers of neurons identiﬁed via GFP expression. This
approach builds on GFP targeting studies by using single-cell
FIGURE 1 | Parvalbumin-positive DH neurons are configured to
mediate presynaptic control of myelinated afferent fiber that
contribute to DH circuits. Figure summarizes a characterization of
PV-positive neurons using a GFP expressing transgenic mouse line
(Hughes et al., 2012). PV-positive DH neurons and their axonal arbors (2,
green) are concentrated in lamina IIi/III. These cells receive input from
myelinated (tactile) primary afferents (1), and their axons appear to target
the central terminals of myelinated primary afferents preferentially, forming
inhibitory axoaxonic synaptic inputs (3). Thus, when this microcircuit is
activated (blue arrow) myelinated afferent input is inhibited, or gated (red
cross). The downstream target of this PV-gated input remains to be
identiﬁed, however, the location of these connections suggests that
neurons in nociceptive circuits may be included.
quantitative PCR (qPCR) to compare gene expression proﬁles
in subsets of identiﬁed neurons. This establishes smaller group-
ings of neurons within a GFP labeled subpopulation that can be
considered distinct according to molecular criteria. Such infor-
mation can then be used to predict the function of different
subpopulations as well as providing novel electrophysiological
and anatomical signatures to identify these populations in sub-
sequent studies. The technique also identiﬁes a series of “marker”
genes and proteins that can be used to subdivide, label, moni-
tor, and manipulate subpopulations of interest. This procedure
has proved valuable in other sensory processing nodes such as
the medial vestibular nucleus (MVN; Sugino et al., 2005; Kodama
et al., 2012). Gene expression proﬁling in the MVN identiﬁed
six distinct neuronal subpopulations. Subsequent combination of
this information with electrophysiological and anatomical data
allowed several populations to be assigned speciﬁc functions in
vestibulo-ocular and vestibulo-cerebellar circuits. The DH repre-
sents an ideal candidate for this type of analysis as the functional
signiﬁcance of its neuron heterogeneity is yet to be understood
and several DH GFP labeled populations are now available. We
believe that such studies could identify novel protein targets
with a high degree of speciﬁcity in terms of the number and
identity of DH neurons that could be manipulated and blunt
pain.
Once molecular screening has been used to identify speciﬁc
protein targets in discrete neuronal subpopulations, the next
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FIGURE 2 | Proposed analysis pathway to resolve DH neuron
heterogeneity. Analyses begin with identiﬁcation of GFP expressing
transgenic mouse lines that label DH neuron populations (1). These
neurons are ﬁrst characterized using electrophysiological and anatomical
approaches, determining the degree of homogeneity/heterogeneity that
exists in the GFP-expressing population (2). Additional transgenic mice
can then be employed that express optogenetic probes to selectively
activate the subpopulations of interest and study their connectivity in DH
circuits (3). GFP-expressing populations can also be subjected to gene
expression proﬁling to further dissect any remaining heterogeneity and
identify novel proteins that are selectively expressed in these
subpopulations (4). This information can then be fed back into the
analysis strategy, further reﬁning the selection of probes to target
smaller DH subpopulations, and identifying unique function and
neuroanatomical features that can then be used to identify these
subpopulations.
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critical step is to determine their relevance and role in nocicep-
tive signal processing (versus other modalities) by establishing
their connectivity. Until recently it has been virtually impos-
sible to obtain such information for complex neural circuits.
The best data for the DH has comes from electrophysiologi-
cal recordings from pairs of “synaptically connected” neurons
in spinal cord slices. These experiments are difﬁcult and typ-
ically result in small sample sizes, especially in the DH where
connectivity rates are low in slices – [10–15% (Lu and Perl,
2003, 2005)]. More recently a series of elegant publications by
the Strassman group have employed laser-scanning microstim-
ulation to investigate connectivity in the DH describing funda-
mental principles for DH synaptic connectivity patterns (Kato
et al., 2009; Kosugi et al., 2013). Notwithstanding the substantial
advances this approach has delivered, laser-scanning micros-
timulation only allows for an identiﬁed neuron’s inputs to be
studied without providing information on the type or types of
neurons where these inputs originate. Fortunately, connectivity
mapping has recently been revolutionized with the introduction
of optogenetic techniques. This approach allows neurons with
the “same genetic signature” to be activated by light. Speciﬁ-
cally, light-sensitive proteins (channel rhodopsins from algae)
are incorporated into a given neuron type. When stimulated
by light of an appropriate wavelength, the channel rhodopsins
either promote or inhibit neuron activity (Fenno et al., 2011).
Optogenetics allows selective activation of neurons within given
circuits and vastly increases the speed and accuracy of connectivity
studies.
So far optogenetics has not yet beenused to study neuronal con-
nectivity within DH circuits. Channel rhodopsins have, however,
been expressed in a subpopulation of polymodal unmyelinated
(Mrgprd-positive) sensory afferents (Wang and Zylka, 2009). DH
neuron responses were recorded in spinal cord slices during selec-
tive “light activation” of Mrgprd-positive unmyelinated afferents.
This is signiﬁcant as there are several classes of polymodal affer-
ents and it is not possible to selectively stimulate them electrically.
The results of this work showed that Mrgprd-positive afferents
provide relatively broad and non-selective input to multiple DH
populations, reinforcing a major premise of this perspective – i.e.,
that functionally discrete DH neuronal populations are critical
for appropriate encoding of sensory information. ChR2 has also
been expressed inNav1.8 positive afferent neurons, amanipulation
that provides optogenetic control of almost all nociceptors (Daou
et al., 2013). In contrast to the Mrgprd experiments, this work was
undertaken in vivo. Light stimulation of the hindpaw resulted in
pain behaviors (i.e., foot withdrawal). These data provide the ﬁrst
proof of concept that optogenetics can be employed under both
in vivo and in vitro conditions and highlights the potential for
these approaches to be used in development and testing of novel
pain therapeutics.
SUMMARY AND CONCLUSION
The challenge of unraveling cellular heterogeneity in the DH
remains a major barrier to understanding how this region encodes
our sensory world. The value of this sort of analysis in the CNS has
been emphasized in a recent review that reinforced Cajal’s original
premise: “A complete understanding of nervous system function
cannot be achieved without the identiﬁcation of its component
cell types” (Fishell and Heintz, 2013). Our failure to meet this
challenge has been largely due to technical limitations, however, a
range of leading-edge techniques including molecular phenotyp-
ing of individual neurons and optogenetic activation of speciﬁc
neuronal populations now allows us to proceed (Figure 2). In
addition, other techniques such as chemogenetic approaches, also
referred to as designer receptors exclusively activated by designer
drug (or DREADD), are likely to form part of the ever-increasing
armory available to manipulate and study the functional role of
neurons in the DH (see Rogan and Roth, 2011; Wess et al., 2013).
Importantly, the application of these technologies in pain research
will require continued advances in molecular probe development,
techniques and equipment to delivery light stimulation to the
spinal cord. The fundamental information provided by these new
techniques will inform future attempts to treat a variety of painful
conditions in which sensory processing and perception are dis-
rupted in the DH. For example our dataset on PV-positive DH
neurons suggest they play a key role in separating tactile and noci-
ceptive information in the spinal cord. Thus, targetted activation
of this functionally discrete DH population may reduce tactile
allodynia, a feature of many chronic pain syndromes where tactile
sensory input excites nociceptive circuits and produces pain. The
information from molecular screening and optogenetic analysis
of these DH neurons ultimately aims to identify pharmacological
agents that are capable of restoring normal sensory function by
abolishing tactile allodynia. Likewise, as additional functionally
discrete DH subpopulations are characterized this same strategy
could lead to new classes of analgesic drugs with very speciﬁc
actions.
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